Philipp Schuetz
Copeptin for the prediction of recurrent cerebrovascular events after transient ischemic attack: results from the CoRisk study.
De Marchis G, Weck A, Audebert H, Benik S, Foerch C, Buhl D, Schuetz P, Jung S, Seiler M, Morgenthaler N, Mattle H, Müller-Stich B, Christ-Crain M, Arnold M, Katan M. Copeptin for the prediction of recurrent cerebrovascular events after transient ischemic attack: results from the CoRisk study. Stroke 2014; 45:2918-23.
28.08.2014Copeptin for the prediction of recurrent cerebrovascular events after transient ischemic attack: results from the CoRisk study.
28.08.2014Stroke 2014; 45:2918-23
De Marchis Gian Marco, Weck Anja, Audebert Heinrich J, Benik Steffen, Foerch Christian, Buhl Daniela, Schuetz Philipp, Jung Simon, Seiler Marleen, Morgenthaler Nils G, Mattle Heinrich Paul, Müller-Stich Beat P, Christ-Crain Mirjam, Arnold Marcel, Katan Mira
Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial
Leuppi J, Tamm M, von Garnier C, Viatte S, Stoeckli R, Schindler C, Scherr A, Müller B, Miedinger D, Maier S, Leibbrandt Y, Henzen C, Duerring U, Drescher T, Briel M, Bodmer M, Bingisser R, Schuetz P, Rutishauser J. Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA 2013; 309:2223-31.
05.06.2013Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial
05.06.2013JAMA 2013; 309:2223-31
Leuppi Jörg D, Tamm Michael, von Garnier Christophe, Viatte Sebastien, Stoeckli Rolf, Schindler Christian, Scherr Andreas, Müller Beat, Miedinger David, Maier Sabrina, Leibbrandt Yolanda, Henzen Christoph, Duerring Ursula, Drescher Tilman, Briel Matthias, Bodmer Michael, Bingisser Roland, Schuetz Philipp, Rutishauser Jonas
Blood biomarkers for personalized treatment and patient management decisions in community-acquired pneumonia
Schuetz P, Litke A, Albrich W, Mueller B. Blood biomarkers for personalized treatment and patient management decisions in community-acquired pneumonia. Curr Opin Infect Dis 2013; 26:159-67.
01.04.2013Blood biomarkers for personalized treatment and patient management decisions in community-acquired pneumonia
01.04.2013Curr Opin Infect Dis 2013; 26:159-67
Schuetz Philipp, Litke Alexander, Albrich Werner, Mueller Beat
Procalcitonin, pyuria and proadrenomedullin in the management of urinary tract infections--'triple p in uti': study protocol for a randomized controlled trial
Drozdov D, Buchkremer F, Litke A, Schuetz P, Huber A, Bürgi U, Fux C, Bock A, Müller B, Albrich W, Ottiger C, Reutlinger B, Thomer A, Meili M, Schwarz S, Kouegbe R, Regez K, Guglielmetti M, Schild U, Conca A, Schäfer P, Triple P study group. Procalcitonin, pyuria and proadrenomedullin in the management of urinary tract infections--'triple p in uti': study protocol for a randomized controlled trial. Trials 2013; 14:84.
22.03.2013Procalcitonin, pyuria and proadrenomedullin in the management of urinary tract infections--'triple p in uti': study protocol for a randomized controlled trial
22.03.2013Trials 2013; 14:84
Drozdov Daniel, Buchkremer Florian, Litke Alexander, Schuetz Philipp, Huber Andreas, Bürgi Ulrich, Fux Christoph A, Bock Andreas, Müller Beat, Albrich Werner, Ottiger Cornelia, Reutlinger Barbara, Thomer Anja, Meili Marc, Schwarz Stefanie, Kouegbe Rita Bossart, Regez Katharina, Guglielmetti Merih, Schild Ursula, Conca Antoinette, Schäfer Petra, Triple P study group
Copeptin adds prognostic information after ischemic stroke: results from the CoRisk study.
De Marchis G, Katan M, Weck A, Fluri F, Foerch C, Findling O, Schuetz P, Buhl D, El-Koussy M, Gensicke H, Seiler M, Morgenthaler N, Mattle H, Müller-Stich B, Christ-Crain M, Arnold M. Copeptin adds prognostic information after ischemic stroke: results from the CoRisk study. Neurology 2013; 80:1278-86.
06.03.2013Copeptin adds prognostic information after ischemic stroke: results from the CoRisk study.
06.03.2013Neurology 2013; 80:1278-86
De Marchis Gian Marco, Katan Mira, Weck Anja, Fluri Felix, Foerch Christian, Findling Oliver, Schuetz Philipp, Buhl Daniela, El-Koussy Marwan, Gensicke Henrik, Seiler Marlen, Morgenthaler Nils G, Mattle Heinrich Paul, Müller-Stich Beat P, Christ-Crain Mirjam, Arnold Marcel
Biomarker-enhanced triage in respiratory infections: a proof-of-concept feasibility trial
Albrich W, Conca A, Schäfer P, Schubert M, De Geest S, Reutlinger B, Irani S, Bürgi U, Huber A, Guglielmetti M, Schild U, Rüegger K, Dusemund F, Schuetz P, Arici B, Litke A, Blum C, Bossart R, Regez K, Müller B. Biomarker-enhanced triage in respiratory infections: a proof-of-concept feasibility trial. Eur Respir J. 2013; 42:1064-75.
24.01.2013Biomarker-enhanced triage in respiratory infections: a proof-of-concept feasibility trial
24.01.2013Eur Respir J. 2013; 42:1064-75
Albrich Werner, Conca Antoinette, Schäfer Petra, Schubert Maria, De Geest Sabina, Reutlinger Barbara, Irani Sarosh, Bürgi Ulrich, Huber Andreas, Guglielmetti Merih, Schild Ursula, Rüegger Kristina, Dusemund Frank, Schuetz Philipp, Arici Birsen, Litke Alexander, Blum Claudine A, Bossart Rita, Regez Katharina, Müller Beat
Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: derivation of a clinical algorithm
Albrich W, Mueller B, Reutlinger B, Buergi U, Irani S, Bregenzer T, Zimmerli W, Christ-Crain M, Rüegger K, Dusemund F, Schuetz P. Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: derivation of a clinical algorithm. BMC Infect Dis 2011; 11:112.
03.05.2011Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: derivation of a clinical algorithm
03.05.2011BMC Infect Dis 2011; 11:112
Albrich Werner, Mueller Beat, Reutlinger Barbara, Buergi Ulrich, Irani Sarosh, Bregenzer Thomas, Zimmerli Werner, Christ-Crain Mirjam, Rüegger Kristina, Dusemund Frank, Schuetz Philipp
Effect of a 14-day course of systemic corticosteroids on the hypothalamic-pituitary-adrenal-axis in patients with acute exacerbation of chronic obstructive pulmonary disease
Schuetz P, Christ-Crain M, Schild U, Süess E, Facompre M, Baty F, Nusbaumer C, Brutsche M, Müller B. Effect of a 14-day course of systemic corticosteroids on the hypothalamic-pituitary-adrenal-axis in patients with acute exacerbation of chronic obstructive pulmonary disease. BMC pulmonary medicine 2008; 8:1.
01.01.2008Effect of a 14-day course of systemic corticosteroids on the hypothalamic-pituitary-adrenal-axis in patients with acute exacerbation of chronic obstructive pulmonary disease
01.01.2008BMC pulmonary medicine 2008; 8:1
Schuetz Philipp, Christ-Crain Mirjam, Schild Ursula, Süess Erika, Facompre Michael, Baty Florent, Nusbaumer Charly, Brutsche Martin, Müller Beat